SynopsisThe global Non-alcoholic Steatohepatitis (NASH) Biomarkers market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026. This report focuses on Non-alcoholic Steatohepat.....
SynopsisEnteral feeding device is a medical device which delivers nutrition or medications directly in the stomach or intestine. Enteral feeding devices are commonly used to feed the specialized diets in elderly or bedridden patients suffering from chronic ailments.
SynopsisDiagnostic test strips are commonly used in clinical analysis of urine and blood, in particular for monitoring glucose concentration. Results are obtained instrumentally or visually as thresholds and quantitative outputs. Dry reagents are applied in the constr.....
SynopsisKetorolac tromethamine, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level. The global Ketorolac Tromethamine mark.....
SynopsisBaby Saline Spray is an isotonic saline solution, with saline concentration adjusted to gently cleanse a baby's nose. The global Baby Saline Spray market was valued at US$ 12630 million in 2023 and is anticipated to reach US$ 20380 million by 2030, witne.....
SynopsisThe vascular doppler system is the standard piece of equipment for the assessment of peripheral vascular disease. The inexpensive, versatile, and portable unit allows the fast and simple, but effective assessment of both venous and arterial disease. It can loc.....
SynopsisIt is a synthetic piperidine derivative, used for preventing histamine-1 from binding with its receptor. In clinical treatment, Levocabastine is used for reducing allergic rhinitis or conjunctivitis symptoms, such as itching and rhinorrhea and asthma. An.....
SynopsisThe global Insomnia Pharmacological Treatment market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 3710.3 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030. The global pharmaceutical market is 1475.....
SynopsisDisruptive Behavior Disorders is often show up against the aggressive behavior related to disease. The global Disruptive Behavior Disorders market was valued at US$ 666.4 million in 2023 and is anticipated to reach US$ 879.9 million by 2030, witnessing a.....
SynopsisReprocessing single-use devices involves reusing instruments that were designed and sold for single-use only. The global Reprocessed Single-Use Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a.....
